PMID- 24063839 OWN - NLM STAT- MEDLINE DCOM- 20140128 LR - 20220311 IS - 1879-1913 (Electronic) IS - 0002-9149 (Linking) VI - 112 IP - 12 DP - 2013 Dec 15 TI - Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention. PG - 1867-72 LID - S0002-9149(13)01701-3 [pii] LID - 10.1016/j.amjcard.2013.08.019 [doi] AB - The simultaneous occurrence of cancer and coronary heart disease is increasing in the Western world. Nevertheless, the influence of cancer on ST elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) has not been investigated extensively. This multicenter registry included patients with STEMI treated with primary PCI from 2006 to 2009. Patients were stratified according to history of cancer, and primary focus lay on all-cause and cardiac mortalities during 1-year follow-up. Adjusted effect sizes were calculated using Cox proportional hazard models. In total, 208 patients had a history of cancer (diagnosed 3 years ago in 57.6%) and 3,215 patients had no history of cancer. Chemotherapy had been administered previously to 23% of patients with cancer. Patients with cancer were older, more frequently women, and more commonly known with previous myocardial infarction or anemia. Reperfusion rates were similar after PCI. Patients with cancer showed greater all-cause (17.4% vs 6.5% in other patients) and cardiac mortalities at 1 year (10.7% vs 5.4% in other patients) because of high early cardiac death (23.8%) in recently diagnosed patients with cancer. After adjustment, a recent cancer diagnosis predicted cardiac mortality at 7 days (hazard ratio 3.34, 95% confidence interval 1.57 to 7.08). The adverse prognosis was partly explained by anemia and occurrence of cardiogenic shock, whereas outcome was independent of cancer treatment. In conclusion, patients with cancer showed greater mortality after STEMI. A cancer diagnosis in the 6 months before primary PCI was strongly associated with early cardiac mortality. CI - Copyright (c) 2013 Elsevier Inc. All rights reserved. FAU - Velders, Matthijs A AU - Velders MA AD - Department of Cardiology, Medical Center Leeuwarden, Leeuwarden, The Netherlands; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: m.a.velders@lumc.nl. FAU - Boden, Helen AU - Boden H FAU - Hofma, Sjoerd H AU - Hofma SH FAU - Osanto, Susanne AU - Osanto S FAU - van der Hoeven, Bas L AU - van der Hoeven BL FAU - Heestermans, Anton A C M AU - Heestermans AA FAU - Cannegieter, Suzanne C AU - Cannegieter SC FAU - Jukema, J Wouter AU - Jukema JW FAU - Umans, Victor A W M AU - Umans VA FAU - Schalij, Martin J AU - Schalij MJ FAU - van Boven, Adrianus J AU - van Boven AJ LA - eng PT - Journal Article PT - Multicenter Study DEP - 20130921 PL - United States TA - Am J Cardiol JT - The American journal of cardiology JID - 0207277 SB - IM MH - Aged MH - Anemia/epidemiology MH - Comorbidity MH - Female MH - Humans MH - Male MH - Middle Aged MH - Myocardial Infarction/*epidemiology/mortality/therapy MH - Neoplasms/*epidemiology MH - Percutaneous Coronary Intervention MH - Prognosis MH - Proportional Hazards Models MH - Registries MH - Shock, Cardiogenic/epidemiology EDAT- 2013/09/26 06:00 MHDA- 2014/01/29 06:00 CRDT- 2013/09/26 06:00 PHST- 2013/06/28 00:00 [received] PHST- 2013/08/06 00:00 [revised] PHST- 2013/08/06 00:00 [accepted] PHST- 2013/09/26 06:00 [entrez] PHST- 2013/09/26 06:00 [pubmed] PHST- 2014/01/29 06:00 [medline] AID - S0002-9149(13)01701-3 [pii] AID - 10.1016/j.amjcard.2013.08.019 [doi] PST - ppublish SO - Am J Cardiol. 2013 Dec 15;112(12):1867-72. doi: 10.1016/j.amjcard.2013.08.019. Epub 2013 Sep 21.